Published in Eur J Surg Oncol on May 28, 2009
Massive localized lymphedema: a clinicopathologic study of 46 patients with an enrichment for multiplicity. Mod Pathol (2015) 0.94
Massive localised lymphoedema: clinical presentation and MR imaging characteristics. Skeletal Radiol (2011) 0.84
Comment on article "Massive localized oedema of the thigh in a morbidly obese patient" (EJSO 2010;36:104-106). Eur J Surg Oncol (2010) 0.75
Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell (1983) 17.87
Epigenetic memory in induced pluripotent stem cells. Nature (2010) 14.31
Coaxial stacking of helixes enhances binding of oligoribonucleotides and improves predictions of RNA folding. Proc Natl Acad Sci U S A (1994) 8.06
Real-time prediction of hand trajectory by ensembles of cortical neurons in primates. Nature (2000) 7.29
A novel family of divergent seven-transmembrane proteins: candidate odorant receptors in Drosophila. Neuron (1999) 6.03
Recruitment of p300/CBP in p53-dependent signal pathways. Cell (1997) 5.10
Cloning of a mitogen-inducible gene encoding a kappa B DNA-binding protein with homology to the rel oncogene and to cell-cycle motifs. Nature (1990) 4.61
Functional role for c-myc in mitogenic response to platelet-derived growth factor. Nature (1984) 4.56
Apg9p/Cvt7p is an integral membrane protein required for transport vesicle formation in the Cvt and autophagy pathways. J Cell Biol (2000) 4.30
Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption. Neoplasia (2001) 4.22
The itinerary of a vesicle component, Aut7p/Cvt5p, terminates in the yeast vacuole via the autophagy/Cvt pathways. J Biol Chem (2000) 3.97
Identification of a novel bacterial sequence associated with Crohn's disease. Gastroenterology (2000) 3.90
Dissection of autophagosome biogenesis into distinct nucleation and expansion steps. J Cell Biol (2000) 3.64
A novel mitogen-inducible gene product related to p50/p105-NF-kappa B participates in transactivation through a kappa B site. Mol Cell Biol (1992) 3.63
Human chromosome 19 and related regions in mouse: conservative and lineage-specific evolution. Science (2001) 3.39
Calmodulin target database. J Struct Funct Genomics (2000) 3.20
Cvt19 is a receptor for the cytoplasm-to-vacuole targeting pathway. Mol Cell (2001) 3.12
Repression by Ikaros and Aiolos is mediated through histone deacetylase complexes. EMBO J (1999) 3.11
Survey of extended-spectrum beta-lactamases in clinical isolates of Escherichia coli and Klebsiella pneumoniae: prevalence of TEM-52 in Korea. J Clin Microbiol (1999) 3.04
The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-kappa B-mediated inhibition. Nature (1992) 2.95
Codon-improved Cre recombinase (iCre) expression in the mouse. Genesis (2002) 2.92
Bone-targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomised phase II trial. Lancet (2001) 2.85
A general method for the detection of large CAG repeat expansions by fluorescent PCR. J Med Genet (1996) 2.83
Soft tissue cephalometric analysis: diagnosis and treatment planning of dentofacial deformity. Am J Orthod Dentofacial Orthop (1999) 2.81
PAC-1: a mitogen-induced nuclear protein tyrosine phosphatase. Science (1993) 2.80
Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice. Science (1993) 2.78
Malignant tumours of the heart: a review of tumour type, diagnosis and therapy. Clin Oncol (R Coll Radiol) (2007) 2.67
The mitogen-activated protein kinase phosphatases PAC1, MKP-1, and MKP-2 have unique substrate specificities and reduced activity in vivo toward the ERK2 sevenmaker mutation. J Biol Chem (1996) 2.60
The role of cholecystectomy in acquired immunodeficiency syndrome. J Am Coll Surg (1997) 2.57
Surface attachment of Salmonella typhimurium to intestinal epithelia imprints the subepithelial matrix with gradients chemotactic for neutrophils. J Cell Biol (1995) 2.53
Regional pattern of white matter microstructural changes in normal aging, MCI, and AD. Neurology (2009) 2.47
Measurement in vivo of proliferation rates of slow turnover cells by 2H2O labeling of the deoxyribose moiety of DNA. Proc Natl Acad Sci U S A (2002) 2.46
Response of patients in phase II studies of chemotherapy in ovarian cancer: implications for patient treatment and the design of phase II trials. Br J Cancer (1989) 2.43
The genetic mapping of a defective LPS response gene in C3H/HeJ mice. J Immunol (1978) 2.43
Complexity of the primary genetic response to mitogenic activation of human T cells. Mol Cell Biol (1989) 2.40
Distinct functional phenotypes of cloned Ia-restricted helper T cells. J Exp Med (1985) 2.39
Design of biomimetic fibrillar interfaces: 1. Making contact. J R Soc Interface (2004) 2.38
Electron microscope studies of heteroduplex DNA from a deletion mutant of bacteriophage phiX-174. Proc Natl Acad Sci U S A (1972) 2.29
Control of MAP kinase activation by the mitogen-induced threonine/tyrosine phosphatase PAC1. Nature (1994) 2.24
Immunosuppressive drugs prevent a rapid dephosphorylation of transcription factor NFAT1 in stimulated immune cells. Proc Natl Acad Sci U S A (1995) 2.24
Ultrabithorax regulates genes at several levels of the wing-patterning hierarchy to shape the development of the Drosophila haltere. Genes Dev (1998) 2.22
Mutations in the LKB1 tumour suppressor are frequently detected in tumours from Caucasian but not Asian lung cancer patients. Br J Cancer (2008) 2.21
A kinase-deficient transcription factor TFIIH is functional in basal and activated transcription. Proc Natl Acad Sci U S A (1995) 2.20
Genetic ablation of parathyroid glands reveals another source of parathyroid hormone. Nature (2000) 2.13
Early loss of heterozygosity on 17q in ovarian cancer. The Abe Ovarian Cancer Genetics Group. Oncogene (1992) 2.13
Evolution of HIV-1 coreceptor usage through interactions with distinct CCR5 and CXCR4 domains. Proc Natl Acad Sci U S A (1997) 2.11
An association study of asthma and total serum immunoglobin E levels for Toll-like receptor polymorphisms in a Japanese population. Clin Exp Allergy (2004) 2.10
Unique and shared functions of different connexins in mice. Curr Biol (2000) 2.10
Expression of chemokine receptors by subsets of neurons in the central nervous system. J Immunol (1997) 2.10
Stroke mechanism in patients with non-valvular atrial fibrillation according to the CHADS2 and CHA2 DS2 -VASc scores. Eur J Neurol (2011) 2.09
Low prevalence of valvular heart disease in 226 phentermine-fenfluramine protocol subjects prospectively followed for up to 30 months. J Am Coll Cardiol (1999) 2.09
Combined chemotherapy with ABCM versus melphalan for treatment of myelomatosis. The Medical Research Council Working Party for Leukaemia in Adults. Lancet (1992) 2.08
Effects of exercise during long-term support with a left ventricular assist device. Results of the experience with left ventricular assist device with exercise (EVADE) pilot trial. Circulation (1997) 2.06
Melasma: histopathological characteristics in 56 Korean patients. Br J Dermatol (2002) 2.05
Prophylactic cranial irradiation for patients with small-cell lung cancer. J Natl Cancer Inst (1995) 2.05
Propofol and convulsions--the evidence mounts. Anaesth Intensive Care (1991) 2.04
Nested case-control study of selected systemic autoimmune diseases in World Trade Center rescue/recovery workers. Arthritis Rheumatol (2015) 2.02
Capacity of multidrug-resistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfaces. Clin Microbiol Infect (2007) 2.00
An outbreak of Campylobacter jejuni infections associated with food handler contamination: the use of pulsed-field gel electrophoresis. J Infect Dis (2000) 1.99
Apg2 is a novel protein required for the cytoplasm to vacuole targeting, autophagy, and pexophagy pathways. J Biol Chem (2001) 1.99
The Vestigial and Scalloped proteins act together to directly regulate wing-specific gene expression in Drosophila. Genes Dev (1998) 1.99
Vascular and metabolic response to isolated small muscle mass exercise: effect of age. Am J Physiol Heart Circ Physiol (2003) 1.97
Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology. Mol Biol Cell (1993) 1.97
Gem: an induced, immediate early protein belonging to the Ras family. Science (1994) 1.94
Immune protection and control of inflammatory tissue necrosis by gamma delta T cells. J Immunol (1994) 1.92
Analysis of hepatitis C virus capsid, E1, and E2/NS1 proteins expressed in insect cells. Virology (1993) 1.92
Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study. J Clin Oncol (1998) 1.91
The regulation and expression of c-myc in normal and malignant cells. Annu Rev Immunol (1986) 1.90
Assembly of an A kinase-anchoring protein-beta(2)-adrenergic receptor complex facilitates receptor phosphorylation and signaling. Curr Biol (2000) 1.90
Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-C. Am J Hum Genet (2000) 1.86
Correlated errors in biased surrogates: study designs and methods for measurement error correction. Stat Med (2005) 1.85
The regulation of AMP-activated protein kinase by H(2)O(2). Biochem Biophys Res Commun (2001) 1.84
Developmental status and reconstitution potential of subpopulations of murine thymocytes. Immunol Rev (1988) 1.82
Effects of reinforcement on standardized test performance. J Appl Behav Anal (1972) 1.82
Localization of the Vpx packaging signal within the C terminus of the human immunodeficiency virus type 2 Gag precursor protein. J Virol (1994) 1.81
Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production. J Exp Med (1993) 1.81
Carbapenem resistance mechanisms in Pseudomonas aeruginosa clinical isolates. Antimicrob Agents Chemother (2001) 1.81
Retrospective analysis of 318 cases of uterine sarcoma. Eur J Cancer (1991) 1.78
Mutational analysis of the hepatitis C virus RNA helicase. J Virol (1997) 1.77
Targeting foreign proteins to human immunodeficiency virus particles via fusion with Vpr and Vpx. J Virol (1995) 1.77
Visual and instrumental colorimetric assessments of small color differences on translucent dental porcelain. J Dent Res (1989) 1.77
Assessing community readiness for prevention. Int J Addict (1995) 1.76
Degradation of lipid vesicles in the yeast vacuole requires function of Cvt17, a putative lipase. J Biol Chem (2000) 1.75
Intracellular transport and virion incorporation of vpx requires interaction with other virus type-specific components. Virology (1993) 1.75
The nitrogenase FeMo-cofactor and P-cluster pair: 2.2 A resolution structures. Science (1993) 1.74
A novel alteration in the structure of an activated c-myc gene in a variant t(2;8) Burkitt lymphoma. Cell (1984) 1.74
MiR-1 and miR-200 inhibit EMT via Slug-dependent and tumorigenesis via Slug-independent mechanisms. Oncogene (2012) 1.73
Results of transvenous embolization of cavernous dural arteriovenous fistula: a single-center experience with emphasis on complications and management. AJNR Am J Neuroradiol (2006) 1.73
Electrical conduction through poly(dA)-poly(dT) and poly(dG)-poly(dC) DNA molecules. Phys Rev Lett (2001) 1.72
Evidence for autoregulation of cystathionine gamma-synthase mRNA stability in Arabidopsis. Science (1999) 1.72
Mania in children with pervasive developmental disorder revisited. J Am Acad Child Adolesc Psychiatry (1997) 1.68
Physician fees and procedure intensity: the case of cesarean delivery. J Health Econ (1999) 1.68
Multiple sets of basal factors initiate transcription by RNA polymerase II. J Biol Chem (1994) 1.68
Activation of NF-kappaB by the human herpesvirus 8 chemokine receptor ORF74: evidence for a paracrine model of Kaposi's sarcoma pathogenesis. J Virol (2001) 1.68
Vascular and metabolic response to cycle exercise in sedentary humans: effect of age. Am J Physiol Heart Circ Physiol (2002) 1.67
Activation of the TFIID-TFIIA complex with HMG-2. Genes Dev (1995) 1.66
Structure and chromosomal location of the gene for endothelial-leukocyte adhesion molecule 1. J Biol Chem (1991) 1.66